Medtronic plc. Ordinary Shares (MDT) Earnings

Medtronic plc. Ordinary Shares

MDT · NYSE

Jul 2026upcoming

Next quarter

Consensus is $1.38 EPS for Jul 2026 across 8 estimates, ranging $1.36 to $1.39.

MDT Apr 2026

Reported Jun 3, 2026

Beat 0.65%

EPS estimate: $1.54
EPS actual: $1.55
Revenue estimate: —
Revenue actual: —
1-day move: +5.11%

Call highlights have not been generated for this quarter.

Symbol: MDT
Type: Stock
Sector: Health Care
Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus
Country: North America
Exchange: NYSE

Medtronic plc , headquartered in Galway, Ireland , is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission - to alleviate pain, restore health, and extend life - unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary.

Key Issues

Bullish view

Revenue increased from $33.5 billion to $36.4 billion and net income also rose, to $4.8 billion, showing that higher sales were accompanied by improved earnings.

Bearish view

Net income increased only from $4.7 billion to $4.8 billion while revenue grew by $2.9 billion, suggesting limited earnings conversion from the reported top-line growth.

Analyst Consensus

See all

Buy

27 analysts

$86

Current

—

Low

$96

Average

—

High

Average target implies +12.20% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Vertex Pharmaceuticals IncorporatedVRTX · NASDAQ-GS